| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.12 | 6e-05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |